3.9 Article

Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer's disease

Publisher

WILEY
DOI: 10.1002/dad2.12231

Keywords

Alzheimer's disease; apolipoprotein E; extracellular vesicles; oxidative stress

Funding

  1. Research Chair Louise & Andre Charron on Alzheimer's disease
  2. Armand-Frappier Fondation
  3. INAF
  4. MRIF

Ask authors/readers for more resources

The study examined the impact of APOE epsilon 4 on antioxidant apolipoproteins in circulating extracellular vesicles and plasma from individuals with cognitive impairment. Results showed that total antioxidant capacity and apolipoprotein D levels in cEVs could differentiate APOE epsilon 4 carriers from controls and predict their progression to AD after 5 years. These findings support the link between APOE epsilon 4 and AD onset, suggesting the potential use of cEVs oxidative signature in early AD diagnosis.
Introduction The substantial link between apolipoprotein E (APOE) epsilon 4 allele and oxidative stress may underlie enhanced Alzheimer's disease (AD) risk. Here, we studied the impact of APOE epsilon 4 on the level of apolipoproteins with antioxidant activities along with oxidative markers in circulating extracellular vesicles (cEVs) and plasma from cognitively impaired-not demented (CIND) individuals converted to AD (CIND-AD). Methods Apolipoproteins E, J, and D and antioxidant response markers were determined in cEVs and plasma using immunoblotting, electrochemical examination, and spectrofluorimetry. Results Total antioxidant capacity and apolipoprotein D levels in cEVs, as judged by regression analysis and cognitive performance correlations, allowed us to differentiate CIND APOE epsilon 4 carriers from controls and to predict their progression to AD 5 years later. Discussion Our findings support the pathological redox linkage between APOE epsilon 4 and AD onset and suggest the use of cEVs oxidative signature in early AD diagnosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available